• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Qiagen NV

Qiagen NV

  1. All
  2. 3rd Party
  1. QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients

    QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients

  2. Gordon Croft, Croft Value

    Headquartered in an 87-year-old building designed to withstand any disaster, Croft-Leominster survives on a flow of contrarian ideas.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.